You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 27, 2024

Details for Patent: 6,131,566


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 6,131,566
Title: Metered dose inhaler for albuterol
Abstract:A metered dose inhaler having all or part of its internal surfaces coated with one or more fluorocarbon polymers, optimally a blend of one or more fluorocarbon polymers in combination with one or more non-fluorocarbon polymers, for dispensing an inhalation drug formation comprising albuterol or a physiologically acceptable salt thereof and a fluorocarbon propellant, optionally in combination with one or more other pharmacologically active agents or one or more excipients.
Inventor(s): Ashurst; Ian Carl (Ware, GB), Herman; Craig Steven (Raleigh, NC), Li-Bovet; Li (Scotch Plains, NJ), Riebe; Michael Thomas (Raleigh, NC)
Assignee: Glaxo Wellcome Inc. (Research Triangle Park, NC) Glaxo Group Limited (Greenford Middlesex, GB)
Application Number:08/831,268
Patent Claim Types:
see list of patent claims
Formulation; Compound; Delivery; Device; Use; Composition;
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 6,131,566: A Detailed Analysis

Introduction

Patent 6,131,566 is a significant intellectual property asset, particularly in the pharmaceutical sector. To fully comprehend its implications, it is crucial to delve into the patent's scope, claims, and the broader patent landscape.

Patent Overview

Patent Title and Description

Patent 6,131,566, while not explicitly detailed in the provided sources, typically involves a specific invention within the pharmaceutical domain. Pharmaceutical patents often cover new drugs, formulations, or methods of treatment.

International Classification

Pharmaceutical patents are usually classified under the International Patent Classification (IPC) system, which helps in categorizing inventions based on their technological fields. For instance, pharmaceuticals might fall under the "A61" section, which includes medical or veterinary science and hygiene[4].

Scope of the Patent

Patent Claims

The scope of a patent is primarily defined by its claims. These claims outline the specific aspects of the invention that are protected by the patent. In the context of pharmaceutical patents, claims might include the chemical structure of the drug, its formulation, the method of administration, or the therapeutic use.

  • Independent and Dependent Claims: Independent claims stand alone and define the invention, while dependent claims build upon the independent claims and provide additional details. Research suggests that narrower independent claims are associated with a higher probability of grant and a shorter examination process[3].

Patent Scope Metrics

Metrics such as independent claim length and independent claim count can be used to measure the scope of a patent. These metrics have been validated to have explanatory power for several correlates of patent scope, including patent maintenance payments, forward citations, and the breadth of patent classes[3].

Claims Analysis

Claim Language

The language used in patent claims is critical. Broader claims may face more scrutiny during the examination process and are less likely to be granted compared to narrower claims. This is because broader claims may overlap with existing patents or lack the specificity required for patentability[3].

Claim Validity and Clarity

The clarity and validity of claims are essential for the patent's enforceability. Patents with unclear or overly broad claims can lead to increased licensing and litigation costs, which can diminish incentives for innovation[3].

Patent Landscape

Technology Areas

The USPTO classifies patents into various technology areas. For pharmaceutical patents, these areas might include "Drugs and Medical Instruments" or "Chemical" fields. The number of patents in these areas has seen significant trends over the years, with a notable decrease in the allowance rate for applications in the "Drugs and Medical Instruments" field[1].

Trends in Patenting

The USPTO data shows that the electrical engineering and mechanical engineering fields dominate the patent landscape, but pharmaceuticals remain a vital sector. The role of information and communication technologies (ICT) also influences the patent landscape, particularly in areas like computer technology and digital communication[4].

Patent Allowance Rates

Historical Context

The probability of receiving a U.S. patent has decreased over time, especially in fields like "Drugs and Medical Instruments" and "Computers and Communications". Only about 55.8% of patent applications filed between 1996 and 2013 were granted without using continuation procedures[1].

Application Characteristics

The origin of the application (U.S. or foreign), the size of the entity filing the application (large or small), and the technology field can all impact the allowance rate. For example, small entities, defined as those with 500 or fewer employees, may face different challenges and have different success rates compared to large entities[1].

Case Study: Similar Patents

Example of a Pharmaceutical Patent

A patent like the one for an aerosol canister employing a polymeric film with improved moisture barrier properties (Canadian Patent 2634151) illustrates the complexity of pharmaceutical and medical device patents. Such patents often involve detailed descriptions of the invention, including the materials used and the method of manufacture[2].

Conclusion

Understanding the scope and claims of a patent like 6,131,566 requires a deep dive into the patent's language, the broader technological field it belongs to, and the trends in patent allowance rates. By analyzing these elements, one can better navigate the patent landscape and ensure that the patent remains a valuable asset.

Key Takeaways

  • Patent Claims: The scope of a patent is defined by its claims, with narrower claims generally having a higher probability of grant.
  • Patent Scope Metrics: Metrics like independent claim length and count are useful in measuring patent scope.
  • Technology Areas: Patents are classified into specific technology areas, with trends varying across these areas.
  • Allowance Rates: The probability of receiving a patent has decreased over time, particularly in certain fields.
  • Application Characteristics: The origin and size of the entity filing the application can impact the allowance rate.

FAQs

What is the typical allowance rate for U.S. patent applications?

The typical allowance rate for U.S. patent applications is around 55.8% without using continuation procedures, although this rate has decreased over time, especially in certain fields[1].

How do patent claims impact the scope of a patent?

Patent claims define the scope of a patent, with narrower claims generally being more likely to be granted and having a shorter examination process compared to broader claims[3].

What are the key metrics for measuring patent scope?

Key metrics include independent claim length and independent claim count, which have explanatory power for several correlates of patent scope[3].

How are patents classified by the USPTO?

Patents are classified into various technology areas based on the World Intellectual Property Organization (WIPO) classification system, which includes 35 technical fields[4].

What factors influence the allowance rate of a patent application?

Factors such as the origin of the application, the size of the entity filing the application, and the technology field can all influence the allowance rate[1].

Sources

  1. Carley, M., Hegde, D., & Marco, A. (2015). What Is the Probability of Receiving a US Patent? Yale Journal of Law & Technology, 17, 203.
  2. Canadian Patents Database. (n.d.). Patent 2634151 Summary.
  3. SSRN. (2016). Patent Claims and Patent Scope.
  4. NSF. (2020). Invention: U.S. and Comparative Global Trends. National Science Foundation.

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 6,131,566

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

International Family Members for US Patent 6,131,566

Country Patent Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
African Regional IP Organization (ARIPO) 791 ⤷  Subscribe
African Regional IP Organization (ARIPO) 9701114 ⤷  Subscribe
Austria 219934 ⤷  Subscribe
Austria 373613 ⤷  Subscribe
>Country >Patent Number >Estimated Expiration >Supplementary Protection Certificate >SPC Country >SPC Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.